Skip to content

GeniPhys

Plug and Play · GeniPhys is developing and commercializing its patented Collymer™ technology platform: a first-in-class polymerizable (scaffold-forming) collagen that supports custom design and fabrication of collagen materials for accelerated and improved tissue restoration and regeneration.

Same space

Also from Plug and Play

All of Plug and Play

Programs

Programs GeniPhys went through
ProgramCohortSource
Plug and PlayNot statedPlug and Play Page

About GeniPhys

"GeniPhys is a groundbreaking lifetech and medtech company focused on developing and commercializing the innovative Collymer™ technology platform. Collymer™ is a unique polymerizable collagen protein designed for in situ scaffold formation, offering a novel approach to tissue restoration and regeneration. This proprietary biopolymer, free of cellular or immunogenic components, minimizes adverse reactions commonly associated with traditional collagen therapies. GeniPhys's biofabrication techniques allow for customizable formats, including self-assembling scaffolds, sheets, tubes, and gradient-density materials tailored for various applications. Preclinical studies have shown promising results in supporting cellularization, vascularization, and innervation, essential for regenerative healing in wound care, breast reconstruction, and vocal fold repair. With significant NSF SBIR funding and FDA 510(k) clearance for advanced wound management, GeniPhys is poised to revolutionize regenerative medicine across multiple fields."

Category
Other
Location
United States
Checked
2h ago

GeniPhys: questions

Which accelerators did GeniPhys go through?

GeniPhys is listed by Plug and Play.

Where is GeniPhys based?

GeniPhys lists United States as its location on Plug and Play's page.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.